156 related articles for article (PubMed ID: 37758451)
1. Gestational choriocarcinoma.
Bogani G; Ray-Coquard I; Mutch D; Vergote I; Ramirez PT; Prat J; Concin N; Ngoi NYL; Coleman RL; Enomoto T; Takehara K; Denys H; Lorusso D; Takano M; Sagae S; Wimberger P; Segev Y; Kim SI; Kim JW; Herrera F; Mariani A; Brooks RA; Tan D; Paolini B; Chiappa V; Longo M; Raspagliesi F; Benedetti Panici P; Di Donato V; Caruso G; Colombo N; Pignata S; Zannoni G; Scambia G; Monk BJ
Int J Gynecol Cancer; 2023 Oct; 33(10):1504-1514. PubMed ID: 37758451
[TBL] [Abstract][Full Text] [Related]
2. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
[TBL] [Abstract][Full Text] [Related]
3. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
4. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
Braga A; Campos V; Filho JR; Lin LH; Sun SY; de Souza CB; da Silva RCAF; Leal EAS; Silveira E; Maestá I; Madi JM; Uberti EH; Viggiano M; Elias KM; Horowitz N; Berkowitz RS
Gynecol Oncol; 2018 Feb; 148(2):239-246. PubMed ID: 29248195
[TBL] [Abstract][Full Text] [Related]
5. Guideline No. 408: Management of Gestational Trophoblastic Diseases.
Eiriksson L; Dean E; Sebastianelli A; Salvador S; Comeau R; Jang JH; Bouchard-Fortier G; Osborne R; Sauthier P
J Obstet Gynaecol Can; 2021 Jan; 43(1):91-105.e1. PubMed ID: 33384141
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.
Sato S; Yamamoto E; Niimi K; Ino K; Nishino K; Suzuki S; Kotani T; Kajiyama H; Kikkawa F
Int J Clin Oncol; 2020 Jan; 25(1):203-209. PubMed ID: 31520175
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom.
Taylor F; Short D; Winter MC; Tidy J; Savage PM; Sarwar N; Hancock BW; Seckl MJ; Coleman RE
Gynecol Oncol; 2015 Feb; 136(2):258-63. PubMed ID: 25542400
[TBL] [Abstract][Full Text] [Related]
8. [Malignant trophoblastic tumors (MTT) treated in the years 1955-2004 in trophoblastic disease center in the Czech Republic (TDC-CZ): clinical-pathological features, curability, typing, pathogenesis].
Zavadil M; Feyereisl J; Safár P; Pán M
Ceska Gynekol; 2004 Dec; 69 Suppl 1():9-15. PubMed ID: 15748020
[TBL] [Abstract][Full Text] [Related]
9. [Progress of the diagnosis and treatment of pulmonary metastasis of gestational choriocarcinoma].
Ma D; Zhang Z; Li S
Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):801-5. PubMed ID: 22008110
[TBL] [Abstract][Full Text] [Related]
10. Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia.
Li L; Wan X; Feng F; Ren T; Yang J; Zhao J; Jiang F; Xiang Y
BMC Cancer; 2018 May; 18(1):585. PubMed ID: 29792175
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
[TBL] [Abstract][Full Text] [Related]
12. Treatment of low-risk gestational trophoblastic neoplasia.
Winter MC
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():67-80. PubMed ID: 33741258
[TBL] [Abstract][Full Text] [Related]
13. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
[TBL] [Abstract][Full Text] [Related]
14. Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics.
Aranake-Chrisinger J; Huettner PC; Hagemann AR; Pfeifer JD
Hum Pathol; 2016 Jun; 52():92-100. PubMed ID: 26980014
[TBL] [Abstract][Full Text] [Related]
15. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
[TBL] [Abstract][Full Text] [Related]
16. Demographics, natural history and treatment outcomes of non-molar gestational choriocarcinoma: a UK population study.
Savage P; Winter M; Parker V; Harding V; Sita-Lumsden A; Fisher RA; Harvey R; Unsworth N; Sarwar N; Short D; Aguiar X; Tidy J; Hancock B; Coleman R; Seckl MJ
BJOG; 2020 Aug; 127(9):1102-1107. PubMed ID: 32146729
[TBL] [Abstract][Full Text] [Related]
17. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
[TBL] [Abstract][Full Text] [Related]
18. Gestational Trophoblastic Tumors: A Timely Review of Diagnostic Pathology.
Hui P
Arch Pathol Lab Med; 2019 Jan; 143(1):65-74. PubMed ID: 30407075
[TBL] [Abstract][Full Text] [Related]
19. [Results of gestational trophoblastic neoplasia treatment in the Slovak Republic in the years from 1993 to 2012].
Korbeľ M; Šufliarsky J; Danihel Ľ; Vojtaššák J; Nižňanská Z
Ceska Gynekol; 2016 Jan; 81(1):6-13. PubMed ID: 26982057
[TBL] [Abstract][Full Text] [Related]
20. Surgery including fertility-sparing treatment of GTD.
Ngu SF; Ngan HYS
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():97-108. PubMed ID: 33127305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
